Accueil   Calls for projects   H2020 Health - calls 2020 - 1.3 Infectious diseases (PCP - PPI)

H2020 Health – calls 2020 – 1.3 Infectious diseases (PCP – PPI)

Call 1 - better health and care
1.3 Infectious diseases (PCP - PPI)

Key features of the call for projects

Opening date: June 25th, 2019

Date de clôture : April 7th, 2020

Dimension : Europe

Funding:

Thématique(s) médicale(s) : All

Secteur(s) industriel(s) :

SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions

Scope: PCP actions targeting consortia of procurers with similar procurement needs that want to procure together the development of innovative integrated care solutions to modernize public services whilst creating growth opportunities for industry and researchers in Europe in addition to new markets. These can include, but are not limited to formal or informal organisational solutions, personal-health and self-care solutions, professional care solutions and ICT-based solutions. This topic is open to proposals for PCP actions in all areas of public sector interest requiring innovative integrated care solutions. It is open both to proposals requiring improvements mainly based on one specific solution/technology field, as well as to proposals requiring end-to-end solutions that need combinations of different innovative solutions from the healthcare point of view.

SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases

Scope: This topic will contribute to the EU One Health Action Plan on Antimicrobial
Resistance and should specifically consider the following:
– Development of proposals for ‘Public Procurement of Innovative Solutions’ for the
implementation of rapid diagnostic tools for infectious diseases in clinical practice.
Proposals should be driven by clearly identified procurement needs of the participating
organisations. In order to ensure compatibility and interoperability between infectious
disease diagnostics and avoid technical/technology standardisation issues, public health
procurers should also develop specifications that are applicable for EU-wide deployment
of the innovative diagnostics.
– Applications should be driven by public and/or private procurers from each participating
country (at national, regional or local level) that have responsibilities and budget control
in the relevant area of supply of health and care services. They should demonstrate the
applicability of the ‘Most Economically Advantageous Tendering’ approach in crossborder
collaboration of public procurers in the EU, defining specific outcome criteria of
importance for patients well-being, and for innovation of public procurement in the area
of infectious diseases and AMR, taking also into account overall economic and societal
benefits, and sex and gender differences when relevant..
– Proposals should include clear communication and outreach strategies aiming to actively
promote and support public health procurement organisations and health care providers
across regions and borders of the EU in adopting relevant innovation procurement
approaches. They should specify measures that will ensure the sustainability of solutions
beyond the lifespan of the proposed project.

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree